(November 30, 2015, 8:43 AM EST) -- LOS ANGELES — Following the lead of a federal multidistrict litigation judge, a California state court judge on Nov. 13 granted summary judgment against about 287 plaintiffs who claim that incretin mimetic diabetes drugs caused pancreatic cancer (In Re: Byetta Cases, No. JCCP 4574, Calif. Super., Los Angeles Co.)....